Cargando…
Mitochonic Acid 5 Improves Duchenne Muscular Dystrophy and Parkinson’s Disease Model of Caenorhabditis elegans
Mitochonic Acid 5 (MA-5) enhances mitochondrial ATP production, restores fibroblasts from mitochondrial disease patients and extends the lifespan of the disease model “Mitomouse”. Additionally, MA-5 interacts with mitofilin and modulates the mitochondrial inner membrane organizing system (MINOS) in...
Autores principales: | Wu, Xintong, Nagasawa, Satoi, Muto, Kasumi, Ueda, Maiko, Suzuki, Chitose, Abe, Takaaki, Higashitani, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455831/ https://www.ncbi.nlm.nih.gov/pubmed/36076995 http://dx.doi.org/10.3390/ijms23179572 |
Ejemplares similares
-
Mitochonic acid 5 attenuates age-related neuromuscular dysfunction associated with mitochondrial Ca(2+) overload in Caenorhabditis elegans
por: Wu, XinTong, et al.
Publicado: (2023) -
Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy
por: Ellwood, Rebecca A., et al.
Publicado: (2021) -
Transcriptome changes during the initiation and progression of Duchenne muscular dystrophy in Caenorhabditis elegans
por: Hrach, Heather C, et al.
Publicado: (2020) -
Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022) -
Vascular therapy for Duchenne muscular dystrophy (DMD)
por: Thapa, Sangharsha, et al.
Publicado: (2023)